Genprex Files S-1 Registration Statement
Ticker: GNPX · Form: S-1 · Filed: May 14, 2025 · CIK: 1595248
Sentiment: neutral
Topics: s-1, registration-statement, pharmaceuticals
TL;DR
Genprex filed an S-1, looks like they're raising capital soon.
AI Summary
Genprex, Inc. filed an S-1 registration statement on May 14, 2025, to register securities under the Securities Act of 1933. The company, headquartered in Austin, TX, is in the pharmaceutical preparations industry. Ryan M. Confer serves as President, CEO, and CFO.
Why It Matters
This S-1 filing indicates Genprex, Inc. is preparing to offer new securities to the public, which could impact its capital structure and stock availability.
Risk Assessment
Risk Level: medium — S-1 filings are often associated with potential stock dilution or new offerings, which can introduce volatility.
Key Numbers
- 333-287250 — SEC File Number (Identifies this specific registration statement)
- 2834 — SIC Code (Indicates industry classification (Pharmaceutical Preparations))
Key Players & Entities
- Genprex, Inc. (company) — Registrant
- Ryan M. Confer (person) — President, Chief Executive Officer and Chief Financial Officer
- 333-287250 (dollar_amount) — SEC File Number
- May 14, 2025 (date) — Filing Date
- Austin, TX (location) — Principal Executive Offices
FAQ
What is the purpose of this S-1 filing for Genprex, Inc.?
The S-1 filing is a registration statement under the Securities Act of 1933, indicating Genprex, Inc. is preparing to offer securities to the public.
Who is the principal executive officer of Genprex, Inc. mentioned in the filing?
Ryan M. Confer is listed as the President, Chief Executive Officer, and Chief Financial Officer of Genprex, Inc.
What is Genprex, Inc.'s primary business classification?
Genprex, Inc. is classified under Standard Industrial Classification code 2834, which pertains to Pharmaceutical Preparations.
Where are Genprex, Inc.'s principal executive offices located?
The principal executive offices of Genprex, Inc. are located at 3300 Bee Cave Road #650-227, Austin, TX 78746.
When was this S-1 registration statement filed with the SEC?
This S-1 registration statement was filed with the Securities and Exchange Commission on May 14, 2025.
Filing Details
This Form S-1 (Form S-1) was filed with the SEC on May 14, 2025 by Ryan M. Confer regarding Genprex, Inc. (GNPX).